Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

Discover top medications for 'treating Osteoporosis'? This page compiles essential information on generic and brand-name drugs specifically used for Osteoporosis treatment.Here, you can explore ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...

Dual-energy x-ray absorptiometry (DXA) can evaluate BMD changes related to medications ... can potentially identify secondary causes of osteoporosis; however, the reliability of this score ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

They say not enough of them are being adequately informed of side effects or complications when coming-off the drug. More for You Rep. Caraveo concedes in Colorado District 8 fight ...

Cancer and osteoporosis patients to benefit from new drug approvalsOpens in new window ] They said the research, published to coincide with World Osteoporosis Day on Sunday, revealed the scale of ...

Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug and are sometimes "scared into" taking it. Doctors acknowledge Prolia ...

The new drug is "a very well-tolerated treatment" for most people, according to Dr Nicky Peel, a clinical trustee at the Royal Osteoporosis Society and metabolic bone physician based in Sheffield.